Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial
-
Published:2023-12
Issue:
Volume:66
Page:102311
-
ISSN:2589-5370
-
Container-title:eClinicalMedicine
-
language:en
-
Short-container-title:eClinicalMedicine
Author:
Marsden JohnORCID,
Kelleher Mike,
Gilvarry Eilish,
Mitcheson Luke,
Bisla Jatinder,
Cape Angela,
Cowden Fiona,
Day Edward,
Dewhurst Jonathan,
Evans Rachel,
Hardy WillORCID,
Hearn Andrea,
Kelly Joanna,
Lowry NatalieORCID,
McCusker Martin,
Murphy Caroline,
Murray Robert,
Myton Tracey,
Quarshie Sophie,
Vanderwaal Rob,
Wareham April,
Hughes Dyfrig,
Hoare Zoë
Funder
Indivior PLC
King's College London
Reference55 articles.
1. Systematic disease among cases of fatal opioid toxicity;Darke;Addiction,2006
2. Diagnostic and statistical manual of mental disorders,2013
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献